BROWSE·page 268 of 1405

Browse EX-10 agreements

16,850 total material contract exhibits.


EXHIBIT 10.5

Trilogy Metals Inc.

THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR UNDER ANY SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED, EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN EXEMPTION THEREFROM.

UNLESS PERMITTED UNDER APPLICABLE SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE JANUARY 12, 2027.

THE SHARES UNDERLYING THE WARRANTS REPRESENTED BY THIS WARRANT CERTIFICATE ARE LISTED ON THE TORONTO STOCK EXCHANGE (“TSX”); HOWEVER, THE SAID SECURITIES CANNOT BE TRADED THROUGH THE FACILITIES OF TSX SINCE THEY ARE NOT FREELY TRANSFERABLE, AND CONSEQUENTLY ANY WARRANT CERTIFICATE REPRESENTING SUCH SECURITIES IS NOT “GOOD DELIVERY” IN SETTLEMENT OF TRANSACTIONS ON TSX.

TRILOGY METALS INC.

COMMON SHARE PURCHASE WARRANT

Dated: September 11, 2026

…

EX-10.5·8-K·CIK 1543418·ACC 0001104659-26-107442·Filed Sep 14, 2026, 14:36 ET

EXHIBIT 10.3

Trilogy Metals Inc.

PARTICIPATION RIGHTS
AGREEMENT

THE UNITED STATES DEPARTMENT OF DEFENSE

** **

- and -

** **

TRILOGY METALS INC.

** **

September 11, 2026

PARTICIPATION RIGHTS AGREEMENT

**THIS AGREEMENT **is made as of the 11th day of September, 2026.

AMONG:

TRILOGY METALS INC., a Company organised and existing under the laws of the Province of British Columbia (hereinafter referred to as the “Company”),

- and -

THE UNITED STATES DEPARTMENT OF DEFENSE, (also referred to herein as the “Department of War” or “Investor”).

WHEREAS

…

EX-10.3·8-K·CIK 1543418·ACC 0001104659-26-107442·Filed Sep 14, 2026, 14:36 ET

EXHIBIT 10.2

Trilogy Metals Inc.

Execution Version

COOPERATION AGREEMENT

among

THE UNITED STATES DEPARTMENT OF DEFENSE (also referred to herein as “Department of War” or “Investor”)

- and -

NOVACOPPER US INC., dba TRILOGY METALS US (“Trilogy US”)

- and -

SOUTH32 USA Exploration Inc.** (“South32 USA Exploration”)**

- and -

AMBLER METALS LLC (“Ambler Metals”)

AUGUST 28, 2026

WHEREAS South32 USA Exploration is an affiliate of South32 Limited;

AND WHEREAS Trilogy US is a wholly-owned subsidiary of Trilogy Metals Inc. (“Trilogy Metals”);

AND WHEREAS South32 USA Exploration and Trilogy US are equal owners of Ambler Metals;

AND WHEREAS this cooperation agreement (the “Agreement”) sets out certain understandings and agreements among the parties hereto in connection with the Transactions (as defined below).

Each of the parties hereto is referred to herein individually as a “Party” and together as the “Parties”.

1. Definitions

…

EX-10.2·8-K·CIK 1543418·ACC 0001104659-26-107442·Filed Sep 14, 2026, 14:36 ET

EXHIBIT 10.8

Star Gold Corp.

The undersigned hereby affirms that there is no Social Security number contained in this document
RECORDING REQUESTED BY: Star Gold Corporation Attn: Lindsay Gorrill, Chairman 1875 N Lakewood Drive, Ste. 200 Coeur d’Alene, ID 83814

…

EX-10.8·10-Q·CIK 1401835·ACC 0001437749-26-030252·Filed Sep 14, 2026, 11:53 ET

EXHIBIT 10.29

Cadeler plc

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. REDACTED INFORMATION HAS BEEN MARKED AS “[REDACTED]”.

Confidential Execution Version

D****ated 11 September 2026

CADELER PLC
as Borrower

DNB BANK ASA
as Mandated Lead Arranger

with

DNB BANK ASA
as Agent

**DNB BANK ASA
as Security Agent **

THE BANKS AND FINANCIAL INSTITUTIONS LISTED IN SCHEDULE 1
as Original Lenders

BRIDGE FACILITY AGREEMENT FOR A LOAN FACILITY OF
up to €220,000,000

Contents

Clause Page

…

EX-10.29·F-4/A·CIK 2063345·ACC 0001104659-26-107368·Filed Sep 14, 2026, 11:02 ET

** **

THIS SOFTWARE DEVELOPMENT AGREEMENT (“Agreement”) is made on 11th September 2026 (“Effective Date”)

BETWEEN

TREASURE GLOBAL INC (Registration No. 7908921), a company incorporated in State of Delaware and having an address for service at 276, 5th Avenue, Suite 704 #739, New York, NY 10001 (the “Company”) of the one part;

AND

MESTIZ TECHNOLOGY SDN BHD [Company Registration No. 200901010248 (853264-U)], a company incorporated under the laws of Malaysia and having its registered address at Unit 48-2 (2nd Floor), Block A, Plaza Sinar, Jalan 8/38D, Taman Sri Sinar, 51200 Segambut, Kuala Lumpur (the “Developer”) of the other part.

(The Company and the Developer may individually be referred to as a “Party” and collectively as the “Parties”.)

RECITALS:

…

EX-10.1·8-K·CIK 1905956·ACC 0001213900-26-099538·Filed Sep 14, 2026, 11:00 ET

REGISTRATION RIGHTS AGREEMENT

** **

**THIS REGISTRATION RIGHTS AGREEMENT **(this “Agreement”), dated as of September 14, 2026, is made and entered into by and among (i) Ondas Inc., a Nevada corporation (the “Parent”), (ii) each of the Persons listed on Schedule A attached hereto (the “Schedule of Holders”) as of the date hereof, (iii) each of the other Persons set forth from time to time on the Schedule of Holders who, at any time, own Registrable Securities and enter into a joinder to this Agreement agreeing to be bound by the terms hereof (each Person identified in the foregoing clauses (ii) and (iii), a “Holder” and, collectively, the “Holders”), and (iv) the Shareholders’ Agent (as defined below).

** **

RECITALS

** **

…

EX-10.1·8-K·CIK 1646188·ACC 0001213900-26-099531·Filed Sep 14, 2026, 10:44 ET

GUARANTY OF PAYMENT

** **

THIS GUARANTY OF PAYMENT (as the same may be hereafter amended, modified, restated, renewed, replaced, supplemented or extended, this “Guaranty”) is made as of September 11, 2026, by Realbotix Corp., an Ontario corporation (the “Guarantor”), in favor of Onconetix, Inc., a Delaware corporation (together with its permitted successors and assigns, “Lender”).

R E C I T A L S:

** **

WHEREAS, contemporaneously herewith, Lender is making available to Realbotix, LLC, a Delaware limited liability company (“Borrower”), loans in an aggregate principal amount of up to $5,000,000 (the “Loans”) pursuant to that certain Grid Promissory Note, dated as of the date hereof, made by Borrower, as maker, in favor of Lender, as payee (together with all extensions, renewals, modifications, substitutions and amendments thereof made in accordance with its terms, the “Note”);

** **

WHEREAS, Borrower is an indirect subsidiary of Guarantor;

** **

…

EX-10.2·8-K·CIK 1782107·ACC 0001213900-26-099524·Filed Sep 14, 2026, 10:39 ET

** **

NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR ANY U.S. STATE. SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATIONS UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAW. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933 ACT.

** **

GRID PROMISSORY NOTE

** **

…

EX-10.1·8-K·CIK 1782107·ACC 0001213900-26-099524·Filed Sep 14, 2026, 10:39 ET

EXHIBIT 10.1

Harvard Apparatus Regenerative Technology, Inc.

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of [______________________], 2026, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and [__________________________________________________________] (the “Purchaser”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act of 1933, as amended (the “Securities Act”) contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to Purchaser, and Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

EX-10.1·8-K·CIK 1563665·ACC 0001437749-26-030244·Filed Sep 14, 2026, 10:11 ET

EXHIBIT 10.2

Harvard Apparatus Regenerative Technology, Inc.

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of September 11, 2026, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and Jerry (Junli) He, an individual and the Chief Executive Officer of the Company (the “Purchaser”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act of 1933, as amended (the “Securities Act”) contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to Purchaser, and Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

EX-10.2·8-K·CIK 1563665·ACC 0001437749-26-030244·Filed Sep 14, 2026, 10:11 ET

EX-10.1

Cardiff Oncology, Inc.


[*] Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

** **

AMENDMENT TO LICENSE AGREEMENT

…

EX-10.1·8-K·CIK 1213037·ACC 0001493152-26-042506·Filed Sep 14, 2026, 09:28 ET